Annual Report 2019

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2019 101 The United Laboratories International Holdings Limited Annual Report 2019 12. PROFIT FOR THE YEAR 2019 2018 RMB’000 RMB’000 Profit for the year has been arrived at after charging (crediting): Auditor’s remuneration 4,865 4,575 Depreciation Depreciation of right-of-use assets 74,698 – Depreciation of property, plant and equipment 588,427 728,755 Less: amount included in research and development expenditures (33,470) (30,125) Less: amount included in temporary production suspension costs in other expenses (1,476) (2,866) 628,179 695,764 Amortisation – intangible assets (included in cost of sales) 12,607 12,284 – prepaid lease payments – 6,585 12,607 18,869 Minimum lease payments in respect of rented premises – 429 Staff costs, including directors’ emoluments Salaries and other benefits costs 1,069,640 956,203 Retirement benefit costs 119,944 99,957 1,189,584 1,056,160 Less: amount included in research and development expenditures (93,362) (54,733) Less: amount included in temporary production suspension costs in other expenses (586) (1,327) 1,095,636 1,000,100 Write-down (reversal of write-down) of inventories, net (included in cost of sales) 8,825 (7,797) Cost of inventories recognised as expenses 4,771,336 4,458,446